The Crystal Structure of Human Transport and Golgi Organization 2 Homolog ( TANGO2 ) Protein Reveals an αββα‐Fold Arrangement
Proteins: Structure, Function, and Bioinformatics · 2026
DOI: 10.1002/prot.70023 ↗At a glance
Journal article in Proteins: Structure, Function, and Bioinformatics, 2026. Written by Anne Cooper and 6 co-authors. Institution: Protein Structure and X-Ray Crystallography Laboratory, Del Shankel Structural Biology Center, University of Kansas, Lawrence, Kansas, USA. Major MEDLINE topics: Vesicular Transport Proteins, Mitochondrial Proteins. 63 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NHGRI NIH HHS, NIH HHS, National Human Genome Research Institute.
Abstract (original language)
Transport and Golgi Organization 2 Homolog (TANGO2) protein deficiency disorder (TDD) is a rare autosomal recessive disorder characterized by multi‐systemic abnormalities and significant phenotypic variability including neurodevelopmental delay, seizures, intermittent ataxia, hypothyroidism, rhabdomyolysis, life‐threatening metabolic derangements, and cardiac arrhythmias. Mutations in TANGO2 result in mitochondrial dysfunction, abnormal lipid homeostasis with cardiolipin deficiency, and impaired Golgi‐ER trafficking in TANGO2 patient‐derived cells. Despite the wide recognition of the clinical manifestations of TDD and numerous molecular studies, the precise function of TANGO2 and the pathophysiology of TDD remain poorly understood. A computationally derived three‐dimensional structure model suggested that TANGO2 adopts an αββα‐fold, similar to the N‐terminal nucleophile aminohydrolase (Ntn) superfamily of proteins, but the experimentally verified structure has not been available thus far. Here, we present the first crystal structure of the recombinant human TANGO2, determined at 1.70 Å resolution. The X‐ray structure data confirmed its predicted tertiary fold with similarity to the Ntn‐hydrolase family of proteins, and the comparative analysis of the active site architecture, including residues involved in catalysis and putative ligand binding site, suggests a potential hydrolase function. Additional examination of the common mutation sites found in TDD patients provides insight regarding their potential effect on protein structure integrity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Protein Structure and X-Ray Crystallography Laboratory, Del Shankel Structural Biology Center, University of Kansas, Lawrence, Kansas, USA.
- Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- New York Structural Biology Center, New York, New York, USA.
- Molecular Graphics and Modeling Laboratory and the Computational Chemical Biology Core, University of Kansas, Lawrence, Kansas, USA.
ORCID profiles: Scott Lovell
Funding
- NHGRI NIH HHS
- NIH HHS
- National Human Genome Research Institute
Cite
APA
Cooper, A., Powers, A., Battaile, K. P., Mohsen, A. W., Johnson, D. K., Lovell, S., & Ghaloul-Gonzalez, L. (2026). The Crystal Structure of Human Transport and Golgi Organization 2 Homolog ( TANGO2 ) Protein Reveals an αββα‐Fold Arrangement. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.70023
Vancouver
Cooper A, Powers A, Battaile KP, Mohsen AW, Johnson DK, Lovell S, et al. The Crystal Structure of Human Transport and Golgi Organization 2 Homolog ( TANGO2 ) Protein Reveals an αββα‐Fold Arrangement. Proteins: Structure, Function, and Bioinformatics. 2026. doi:10.1002/prot.70023
BibTeX
@article{Cooper2026,
author = {Cooper, Anne and Powers, Alyssa and Battaile, Kevin P and Mohsen, Al-Walid and Johnson, David K and Lovell, Scott and Ghaloul-Gonzalez, Lina},
title = {The Crystal Structure of Human Transport and Golgi Organization 2 Homolog ( TANGO2 ) Protein Reveals an αββα‐Fold Arrangement},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2026},
doi = {10.1002/prot.70023}
}
EUVIMED